Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality improvement cardiovascular care Kwara-I (QUICK-I)
BMC Public Health, Volume 11, Article 186, Year 2011
Notification
URL copied to clipboard!
Description
Background: Cardiovascular diseases (CVD) are a leading contributor to the burden of disease in low- and middle-income countries. Guidelines for CVD prevention care in low resource settings have been developed but little information is available on strategies to implement this care. A community health insurance program might be used to improve patients' access to care. The operational research project "QUality Improvement Cardiovascular care Kwara - I (QUICK-I)" aims to assess the feasibility of CVD prevention care in rural Nigeria, according to international guidelines, in the context of a community based health insurance scheme. Methods/Design. Design: prospective observational hospital based cohort study. Setting: a primary health care centre in rural Nigeria. Study population: 300 patients at risk for development of CVD (patients with hypertension, diabetes, renal disease or established CVD) who are enrolled in the Hygeia Community Health Plan. Measurements: demographic and socio- economic data, physical and laboratory examination, CVD risk profile including screening for target organ damage. Measurements will be done at 3 month intervals during 1 year. Direct and indirect costs of CVD prevention care will be estimated. Outcomes: 1) The adjusted cardiovascular quality of care indicator scores based on the "United Kingdom National Health Services Quality and Outcome Framework". 2) The average costs of CVD prevention and treatment per patient per year for patients, the clinic and the insurance company. 3) The estimated net health care costs of standard CVD prevention care per quality-adjusted life year gained. Analysis: The primary outcomes, the score on CVD quality indicators and cost data will be descriptive. The quality scores and cost data will be used to describe the feasibility of CVD prevention care according to international guidelines. A cost-effectiveness analysis will be done using a Markov model. Discussion. Results of QUICK-I can be used by policy makers and professionals who aim to implement CVD prevention programs in settings with limited resources. The context of the insurance program will provide insight in the opportunities community health insurance may offer to attain sustainable chronic disease management programs in low resource settings. Trial registration. This protocol has been registered at ISRCTN, ID number: ISRCTN47894401. © 2011 Hendriks et al; licensee BioMed Central Ltd.
Available Materials
https://efashare.b-cdn.net/share/pmc/articles/PMC3073902/bin/1471-2458-11-186-S1.PDF
https://efashare.b-cdn.net/share/pmc/articles/PMC3073902/bin/1471-2458-11-186-S2.PDF
Authors & Co-Authors
Hendriks, Marleen Elisabeth
Netherlands, Amsterdam
Universiteit Van Amsterdam
Brewster, Lizzy M.
Netherlands, Amsterdam
Universiteit Van Amsterdam
Wit, Ferdinand W.N.M.
Netherlands, Amsterdam
Universiteit Van Amsterdam
Akeem Bolarinwa, Oladimeji Akeem
Nigeria, Ilorin
University of Ilorin
Odusola, A.
Netherlands, Amsterdam
Universiteit Van Amsterdam
Nigeria, Lagos
Pharmaccess Foundation
Redekop, William
Netherlands, Rotterdam
Erasmus Universiteit Rotterdam
Bindraban, Navin
Netherlands, Amsterdam
Universiteit Van Amsterdam
Vollaard, Albert M.
Netherlands, Amsterdam
Pharmaccess Foundation
Alli, Shade
Nigeria, Apapa
Lagoon Hospital
Adenusi, Peju
Nigeria, Lagos
Hygeia Nigeria Ltd
Agbede, Kayode
Nigeria
Ogo Oluwa Hospital
Akande, Tanimola Makanjuola
Nigeria, Ilorin
University of Ilorin
Lange, Joep M.A.
Netherlands, Amsterdam
Universiteit Van Amsterdam
Schultsz, Constance
Netherlands, Amsterdam
Universiteit Van Amsterdam
Viet Nam, Ho Chi Minh City
Oxford University Clinical Research Unit
Statistics
Citations: 23
Authors: 14
Affiliations: 9
Identifiers
Doi:
10.1186/1471-2458-11-186
e-ISSN:
14712458
Research Areas
Health System And Policy
Noncommunicable Diseases
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative
Study Locations
Nigeria